The Law Offices of Frank R. Cruz announces an investigation of Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC) on behalf of investors concerning the Company’s possible violations of federal securities laws.

What Is The Investigation About?
On July 8, 2026, reports emerged that a former Alignment executive had filed a whistleblower lawsuit alleging that the Company manipulated its finances to boost its stock price and executive compensation. Specifically, the lawsuit claims that Alignment deliberately misclassified routine operating expenses (such as routine software maintenance and production support) as capital expenditures within its technology sector and that this accounting maneuver artificially inflated the Company’s adjusted EBITDA and allowed it to report its “first full year of positive adjusted EBITDA as a public company“.

On this news, Alignment’s stock price fell $4.02, or 16.7%, to close at $20.03 per share on July 8, 2026, thereby injuring investors.